SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

12 Months Ended

Jun. 30, 2019

Accounting Policies [Abstract]

Summary of revenue by solution

The components of revenues by solution which reflect a disaggregation of revenue by contract type are as follows (dollar amounts in thousands):

	Year Ended June 30,
	2019		% Total		2018(2)		% Total		2017(2)		% Total
REVENUES BY SOLUTION:
Mailbacks	$	24,501	55.2	%	$	22,272	55.5	%	$	24,625	64.5	%
Route-based pickup services	9,029		20.4	%	7,492		18.7	%	6,348		16.6	%
Unused medications	6,936		15.7	%	5,907		14.7	%	3,377		8.8	%
Third party treatment services	290		0.7	%	891		2.2	%	413		1.1	%
Other (1)	3,556		8.0	%	3,579		8.9	%	3,425		9.0	%
Total revenues	$	44,312	100.0	%	$	40,141	100.0	%	$	38,188	100.0	%

(1) The Company’s other products include IV poles, accessories, containers, asset return boxes and other miscellaneous items with single performance obligations.

(2) Certain prior year amounts have been reclassified to conform to current year presentation.

Schedule of impact of new accounting guidance

The impact of adopting the new accounting guidance on the Company's consolidated statement of operations for the year ended June 30, 2019 was as follows (in thousands):

	Year Ended June 30, 2019
	As Reported		Adjustments		Balance Without Adoption
Revenues	$	44,312	$	267	$	44,579
Cost of revenues	31,042		162		31,204
Gross profits	13,270		105		13,375
Selling, general and administrative	12,003		49		12,052
Operating income	447		56		503
Net income	$	214	$	56	$	270

The impact of adopting the new accounting guidance on the Company's consolidated balance sheet as of June 30, 2019 was as follows (in thousands):

	June 30, 2019
	As Reported			Adjustments			Balance Without Adoption
Current contract asset	$	260		$	(260	)	$	—
Prepaid and other current assets	922			(49		)	873
Total current assets	18,753			(309		)	18,444
Total assets	36,040			(309		)	35,731
Current contract liability(1)	2,502			(27		)	2,475
Total current liabilities	8,178			(27		)	8,151
Contract liability, net of current portion(1)	503			—			503
Total liabilities	9,914			(27		)	9,887
Accumulated deficit	(1,505		)	(282		)	(1,787		)
Total stockholders' equity	26,126			(282		)	25,844
Total liabilities and stockholders' equity	$	36,040		$	(309	)	$	35,731

(1): Prior period contract liabilities were referred to as deferred revenue.

Allowance for doubtful accounts

See rollforward of allowance activity below:

Allowance for Doubtful Accounts	Balance Beginning of Year		Charges to Expense		Write-offs /Recoveries			Balance End of Year
2019	$	102	$	81	$	(51	)	$	132
2018	$	78	$	62	$	(38	)	$	102
2017	$	63	$	20	$	(5	)	$	78

Schedule of stock-based compensation expense

Total stock-based compensation expense for the fiscal years ended June 30, 2019, 2018 and 2017 are as follows:

	Year Ended June 30,
	2019		2018		2017
Stock-based compensation expense included in:
Cost of revenue	$	9	$	43	$	41
Selling, general and administrative	391		433		455
Total	$	400	$	476	$	496

Schedule of stock option valuation assumptions

The fair value of the Company’s stock options was estimated on the grant date using the Black-Scholes option-pricing model with the following assumptions:

	Year Ended June 30,
	2019		2018		2017
Weighted average risk-free interest rate	2.6	%	1.2	%	1.1	%
Weighted average expected volatility	44	%	48	%	47	%
Weighted average expected life (in years)	3.08		3.03		5.15
Dividend yield	—		—		—

Schedule of accrued liabilities

The components of Accrued Liabilities on the balance sheet as of June 30, 2019 and 2018 are as follows:

	As of June 30,
	2019		2018
Accrued payroll	$	376	$	389
Customer-related payables	341		334
Accrued rebates	493		327
Other	1,003		1,011
Total	$	2,213	$	2,061